In addition, the following exclusion criteria were applied: Young individuals with previously diagnosed pathologies, generating arrhythmias or oxidative stress including: i) pathologies that cause secondary arrhythmias such as hyperthyroidism, myxedema, anemia, hypotension, hypoglycemia, febrile syndrome, myocarditis, orpheochromocytoma
At CROI, Corley presented results from a secondary analysis looking at the effects of semaglutide on epigenetic aging biomarkers
Alveolar bone resorption and alveolar bone morphometric parameters were imaged at an isotropic voxelsize of 10 m, using a microCT Cone Beam 1172 SkyScan system (Skyscan, Kontich, Belgium) operating at a peak voltage of 100 kV and 100 A with a 0.5 mm aluminium filter
As of 2025, retatrutide is still in Phase 3 clinical trials
Tramadol (hSERT Ki 500 nM)
Our team considers: Inflammation and immune balance Nutrient status Skin goals and tolerance Overall longevity strategy We offer topical 2% copper peptides and carefully evaluate injectable options when appropriate